KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $2.16.

  • Quest Diagnostics' EPS (Weighted Average and Diluted) rose 854.27% to $2.16 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.52, marking a year-over-year increase of 1451.61%. This contributed to the annual value of $7.69 for FY2024, which is 267.02% up from last year.
  • Latest data reveals that Quest Diagnostics reported EPS (Weighted Average and Diluted) of $2.16 as of Q3 2025, which was up 854.27% from $2.47 recorded in Q2 2025.
  • Quest Diagnostics' 5-year EPS (Weighted Average and Diluted) high stood at $4.96 for Q2 2021, and its period low was $0.92 during Q4 2022.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $2.03 (2024), whereas its average is $2.38.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first surged by 37397.26% in 2021, then plummeted by 7070.06% in 2022.
  • Quarter analysis of 5 years shows Quest Diagnostics' EPS (Weighted Average and Diluted) stood at $3.14 in 2021, then plummeted by 70.7% to $0.92 in 2022, then surged by 84.78% to $1.7 in 2023, then rose by 14.71% to $1.95 in 2024, then rose by 10.77% to $2.16 in 2025.
  • Its EPS (Weighted Average and Diluted) was $2.16 in Q3 2025, compared to $2.47 in Q2 2025 and $1.94 in Q1 2025.